Venture Secondary Summit 2025: Key takeaways
The inaugural Venture Secondary Summit, held in California from April 1–2, convened leadingvoices from across the venture capital secondaries ecosystem. The two-day event featured arange of discussions—from market sizing and structural innovation, to growth expectations anddifferentiation strategies—drawing participation from firms including Jefferies, Kline Hill,Lazard, Campbell Lutyens, StepStone Group, Goldman Sachs, and more. To glean further […]
Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First Prescription Digital Therapeutic for the Preventive Treatment of Episodic Migraine in the United States
Click Therapeutics, Inc., (“Click”) a leader in prescription medical treatments as both prescription digital therapeutics and software-enhanced drug™ therapies, has obtained FDA marketing authorization for the first prescription digital therapeutic for the preventive treatment of episodic migraine. FDA granted the De Novo Classification Request for the company’s prescription digital therapeutic, CT-132, for the preventive treatment […]
Summit Spine Expands with a Unique Physician-Centric Model in Interventional Spine Care
Summit Spine & Joint Centers (“Summit”), a leading minimally invasive spinal services platform, is revolutionizing the field with a distinctive structure that combines hospital affiliations, and Ambulatory Surgery Center (ASC) ownership opportunities for physicians. This innovative model has been the driving force behind the company’s sustained growth over the past ten years. Summit completed a recapitalization with […]
Omada Partners with CVS Caremark on Weight Management Program
Omada Health is joining forces with CVS Health’s Caremark as part of the pharmacy benefit manager’s weight management program. This marks Omada’s second partnership with a major PBM, following its team-up with Cigna’s Express Scripts within its EncircleRx initiative. Omada offers an enhanced care track program for GLP-1 drugs that seeks to make it easier […]
Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease
In the latest investment in the immunology space, Sanofi has agreed to a $600 million upfront payment to buy Dren Bio’s investigational bispecific antibody DR-0201 in a deal announced Thursday. The asset is a targeted cell engager that binds to the CD20 protein on B cells, tagging them for destruction. In early clinical studies, DR-0201 has demonstrated the ability […]
Key Takeaways from HPE Miami 2025: A Cautious Yet Evolving Private Equity Landscape
The Revelation Partners team was in Miami March 5-6 for the HPE Miami Conference. The conference, which has become the “go-to” event for private equity sponsors (who can pass up a trip to Miami in March?), brought together thousands of attendees to discuss the current state of the market, emerging trends, and challenges facing the […]
Dassault Systèmes Intensifies the MEDIDATA Commitment to Patient Experience with Investment in Click Therapeutics for Digital Therapeutics beyond Clinical Trials
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its investment in Click Therapeutics, a leader in prescription digital therapeutics and software-enhanced drug therapies. The transaction advances Dassault Systèmes’ transformation of the patient experience in life sciences and healthcare through end-to end technology solutions used across the healthcare ecosystem. The transaction strengthens the existing relationship between Dassault Systèmes’ […]
Arbor Raises $74M Amid Genetic Medicine’s Funding Slump
Arbor Biotechnologies on Tuesday announced a new $74 million fundraise that comes as many of its peers in genetic medicine struggle to secure venture investment. The Series C round led by Arch Venture Partners and TCGX will help Arbor advanced its lead program into clinical testing. Arbor is developing the gene editing therapy, dubbed ABO-101, […]
Riding the AI Wave in Medical Imaging: Navigating Adoption Hurdles, Disruption, and Scaling Success
In the current AI landscape dominated by headlines about Large Language Models (LLMs) like GPT-4 and companies like DeepSeek, it’s crucial to recognize that artificial intelligence encompasses a far broader spectrum of applications and technologies. While generative AI and chatbots capture public imagination, the healthcare industry, particularly medical imaging, leverages AI in ways that are […]
VitalConnect, Inc. Secures $100 Million in Financing
VitalConnect®, Inc., a leader in biosensor technology, specializing in ambulatory cardiac monitoring, today announced the closing of $100 million in financing through a combination of equity and debt capital. The equity financing was led by new investor Ally Bridge Group, with significant participation from the Company’s existing investors, including EW Healthcare Partners, MVM and Revelation […]